Filter by patients with: All

What is Raltegravir (RAL)?

Category: Prescription Drugs

Most popular types: Isentress

false

Raltegravir is an integrase strand transfer inhibitor agent used in the treatment of HIV-1 infection in combination with other antiretroviral agents.

See patients taking Raltegravir (RAL)

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Human immunodeficiency virus (HIV) 257 50
Support immune health 7 3
Increase effect of another treatment 3 2
Acquired immune deficiency syndrome (AIDS) 2 1
Myalgic encephalomyelitis/chronic fatigue syndrome 1 1
Participate in clinical trial 1 1
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See all 321 patients that have taken Raltegravir (RAL)

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 6
Mild 9
None 39

Commonly reported side effects and conditions associated with Raltegravir (RAL)

Side effect Patients Percentage
Headaches 4
Diarrhea 2
Nausea 2
Agitation 1
Anxious mood 1
Chills 1

Show all 16 reported side effects

Why patients stopped taking Raltegravir (RAL)

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 11
Other 7
Course of treatment ended 4
Change in health plan coverage 2
Expense 2
Side effects too severe 2
Did not seem to work 1
See all 23 patients who've stopped taking Raltegravir (RAL)

Duration

Stopped taking Raltegravir (RAL)

Duration Patients Percentage
Less than 1 month 2
1 - 6 months 1
6 months - 1 year 2
1 - 2 years 5
2 - 5 years 5
5 - 10 years 8
Adherence
Adherence Evaluations Percentage
Always 43
Usually 10
Sometimes 1
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 2
A little hard to take 18
Not at all hard to take 34
Cost per month
Cost per month Evaluations Percentage
$200+ 5
$100-199 1
$50-99 3
$25-49 6
< $25 17
Not specified 22

What people switch to and from

Patients started taking Raltegravir (RAL) after stopping:

Treatment Patients Percentage
Nevirapine (NVP) (Viramune) 2
Abacavir-lamivudine (ABC/3TC) (Epzicom) 1
Darunavir (DRV) (Prezista) 1
Efavirenz-Emtricitabine-Tenofovir disoproxil fumarate (Atripla) 1
Tenofovir disoproxil fumarate (Viread) 1

Show all 6 treatments patients report switching from

Patients stopped taking Raltegravir (RAL) and switched to:

Treatment Patients Percentage
Triumeq 4
Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV) (Trizivir) 1
Bictegravir-emtricitabine-tenofovir alafenamide (BIC/FTC/TAF) (Biktarvy) 1
Dolutegravir (DTG) (Tivicay) 1
Efavirenz-Emtricitabine-Tenofovir disoproxil fumarate (Atripla) 1

Show all 6 treatments patients report switching to

Last updated:

9 patient evaluations for Raltegravir (RAL)

Sort by: Most recent

Dec 12, 2016 (Started Feb 03, 2011)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 800 mg Daily
  • 0 helpful marks

Aug 2, 2014 (Started Mar 15, 2013)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    Moderate (peripheral neuritis)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 800 mg Daily
Cost: < $25 monthly
  • 0 helpful marks

Aug 8, 2012 (Started Jun 17, 2010)

  • Effectiveness
    Moderate (for human immunodeficiency virus (HIV))
  • Side effects
    Mild (headaches, chills)
  • Adherence
    Usually
  • Burden
    Not at all hard to take
Dosage: 800 mg Daily
Cost: $25-49 monthly
Side effects: headaches, chills

Jun 28, 2010 (Started Jun 17, 2010)

  • Effectiveness
    Can't tell (for human immunodeficiency virus (HIV))
  • Side effects
    Moderate (headaches, chills)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 800 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: $25-49 monthly
Side effects: headaches, chills
  • 0 helpful marks
Last updated:
Showing 3 of 9 patient evaluations for Raltegravir (RAL)